Viewing Study NCT03312335


Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2026-02-20 @ 8:15 PM
Study NCT ID: NCT03312335
Status: COMPLETED
Last Update Posted: 2020-08-19
First Post: 2017-09-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosus
Sponsor: Onur Boyman, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lupus Erythematosus, Systemic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lupus Erythematosus, Systemic View
None SLE View
None Interleukin-2 View
None IL-2 View
None T-Lymphocytes, Regulatory View
None Treg View